期刊文献+

吸烟对稳定期COPD患者外周血Th17/Treg免疫平衡影响研究 被引量:8

Investigation of effect of smoking on Th17/Treg in peripheral blood of stable COPD patients
下载PDF
导出
摘要 目的:观察稳定期COPD患者和健康人吸烟和非吸烟者外周血中的T辅助细胞( Th细胞)17和调节性 T 细胞( Treg 细胞)比例差异,分析吸烟对稳定期 COPD 患者 Th17/Treg的影响,探讨吸烟引发COPD发生发展的可能免疫机制。方法①选取2012年12~2013年4月我院就诊的稳定期COPD 患者73例,分别设为不吸烟组46例、吸烟组27例,同时选取同期进行社区流行病学调查及医院体检中心的健康人26例设为对照组,不吸烟组16例和吸烟组10例。所有受试者均填写统一的调查问卷,明确个人史,现病史、用药史,完善肺功能检查;②各组受试者空腹6 h后清晨抽取静脉血2 ml,应用细胞内染色的流式细胞术检测各组受试者外周血中 Th17/Treg 细胞比例;③多组间比较采用单因素方差分析,多组内两两比较采用SNK 检验(方差齐)和 Games-Howell 法(方差不齐), Th17/Treg 细胞的比例与吸烟指数及肺功能关系用Spearman相关分析进行相关性检验。结果① COPD组吸烟者和非吸烟者与对照组吸烟与非吸烟者外周血Th17/Treg细胞比例分别为(3.23±0.86)%、(2.97±0.98)%和(2.07±0.40)%、(1.96±0.30)%,多组间比较差异呈显著性(P〈0.01);② COPD患者吸烟组和非吸烟组第1秒用力呼气容积实测值与预计值比(FEV1% prep)分别为(55.66±20.61)%、(64.04±13.80)%,第1秒用力呼气容积/用力肺活量比(FEV1/FVC)分别为(55.23±10.52)%、(62.62±5.49)%,两组间差异存在统计学意义(P〈0.05);③外周血Th17/Treg细胞比例与FEV1% prep和FEV1/ FVC存在显著相关性(r=-0.517、-0.512,P值分别为0.00,0.00)。结论吸烟与COPD患者Th17/Treg细胞比例失衡相关; Th17/Treg细胞比例失衡可能参与了发病和进展过程;吸烟可能通过引起Th17/Treg细胞比例失衡导致COPD的发生发展。 Objective To observe and compare the changes in proportion of T help cells 17 (Th17) to regu-latory T cells ( Treg cells) in peripheral blood among stable COPD patients, smokers and non-smokers. Methods 73 COPD patients at stable stage were divided into the group A ( non-smoker) and the group B ( smoker) by their smoking history. Another 26 healthy volunteers from epidemiology study and medical examination center were taken as the control group, which included 16 smokers and 10 non-smokers. All the participants filled out the unified ques-tionnaire, recording about their general condition, smoking history, past medical history and pulmonary function. Ev-ery group's blood sample was collected in the morning 6 hours after empty stomach. The proportion of Th17/Treg in peripheral blood was measured by flow cytometry method. Results The proportions were (3. 23 ± 0. 86), (2. 97 ± 0. 98), (2. 07 ± 0. 40), (1. 96 ± 0. 30) respectively in the groups A and B and the control group (P〈0. 05). The FEV1% prep and FEV1/FVC% in the group A and the group B were (55. 66 ± 20. 61)%, (64. 04 ± 13. 80)% and (55. 23 ± 10. 52)%, (62. 62 ± 5. 49)%. The proportion of Th17/Treg in peripheral blood and FEV1% prep and FEV1/FVC% was correlated (r= -0. 517, -0. 512 and P=0. 00). Conclusion Immune disorders may exist in COPD patients and smokers, and the proportion of Th17/Treg may be involved in the onset and process of the patho-genesis of COPD.
出处 《临床肺科杂志》 2014年第7期1165-1168,共4页 Journal of Clinical Pulmonary Medicine
基金 国家自然科学基金资助课题(No 81260590)
关键词 吸烟 慢性阻塞性肺疾病稳定期 TH17 TREG 肺功能 流式细胞仪 smoke stable COPD Th17/Treg pulmonary function flow cytometry
  • 相关文献

参考文献15

  • 1Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary[J]. Am J Respir Crit Care Med, 2001, 163 : 1256 - 1276.
  • 2Celli BR, Mac Nee W, Agusti A, et al. Standards for the diagno- sis and treatment of patients with COPD : a summary of the ATS/ ERS position paper[J]. Eur Respir J, 2004, 23:932 -946.
  • 3Louten J, Boniface K, de Waal Malefyt R. Development and function of TH17 cells in health and disease[J]. J Allergy Clin Immunol, 2009( 123 ) : 1004 - 1011.
  • 4Voelkel N, Taraseviciene-Stewart L. Emphysema: an autoimmune vascular disease[J] ? Proc Am Thorac Soc, 2005(2) :23 -25.
  • 5Agustt A, MacNee W, Donaldson K, Cosio M. Hypothesis : does COPD have an autoimmune component[ J]? Thorax, 2003, (58) : 832 - 834.
  • 6Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease[J]. Nat Rev Immunol, 2008(8) :183 -192.
  • 7Burge S, Wedzicha JA. COPD exacerbations : definitions and classifications [ J ]. Eur Respir J, 2003 (21) : 546 - 553.
  • 8Senior RM, Anthonisen NR. Chronic obstructive pulmonary disease [ J ]. Am JRes Crit Care Med, 1998,157 : 139 - 147.
  • 9T zortzaki EG, Siafakas NM. A hypothesis for the initiation of COP D[J]. Eur Respir J, 2009 Aug;34(2):310-315.
  • 10Motz GT, Eppert BL, Sun G, et al. Persistence of lung CD8 T cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke-induced emphysema [ J ]. J Immunol, 2008 ( 181 ) :8036 - 8043.

二级参考文献7

共引文献33

同被引文献90

  • 1崔节伟,杨静,孙奕.内皮微粒膜表面标记物的检测与意义[J].医学研究生学报,2011,24(7):767-770. 被引量:3
  • 2慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2039
  • 3刘珊,宛超,徐海滨,孙贵范.吸烟人群尿中8-OHdG水平的观察[J].华南预防医学,2006,32(3):52-53. 被引量:6
  • 4于智敏.中医学“毒”的病机研究[J].中国中医基础医学杂志,2006,12(12):895-896. 被引量:18
  • 5常富业,王永炎,李辉,李云.《内经》毒论诠析[J].时珍国医国药,2007,18(11):2684-2685. 被引量:23
  • 6Francois Maltais,Marc Decramer,Richard Casaburi,et al.An Official American Thoracic Society/European Respiratory Society Statement:Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease[J].Am J Respir Crit Care Med,2014,189(9):15-62.
  • 7Ji Ye Jung,Dong Pil Choi,Sungho Won,et al.Relationship of Vitamin D Binding Protein Polymorphisms and Lung Function in Korean Chronic Obstructive Pulmonary Disease[J].Yonsei Med J,2014,55(5):1318-1325.
  • 8Xiaodan Wu,Xiaoru Sun,Chengshui Chen,et al.Dynamic gene expressions of peripheral blood mononuclear cells in patients with acute exacerbation of chronic obstructive pulmonary disease:a preliminary study[J].Crit Care,2014,18(6):508-509.
  • 9Geetanjali Bade,Meraj Alam Khan,Akhilesh Kumar Srivastava,et al.Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease[J].Int J Chron Obstruct Pulmon Dis,2014,9(7):759-773.
  • 10Shambhu Aryal,Enrique Diaz-Guzmanand David M Mannino.Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes[J].Int J Chron Obstruct Pulmon Dis,2014,9(7):1145-1154.

引证文献8

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部